Jun Naniwa

479 citations

19 papers · 399 indexed · h-index 13

Impact in

Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments

Papers in ⓘ

Molecular Biology 12
- PI3K/AKT/mTOR signaling in cancer 8
Reproductive Medicine 9
- Ovarian cancer diagnosis and treatment 8
- Endometriosis Research and Treatment 2

Co-authors: Junzo Kigawa (19 shared papers)Hiroaki Itamochi (19 shared papers)Tetsuro Oishi (17 shared papers)Muneaki Shimada (17 shared papers)Naoki Terakawa (13 shared papers)Seiya Sato (13 shared papers)Shinya Sato (14 shared papers)Yasunobu Kanamori (6 shared papers)
Journals: International Journal of Gynecological Cancer (5 papers)Cancer Science (3 papers)Human Cell (2 papers)Oncology Reports (2 papers)Cancer Research (2 papers)
Partner nations: Japan

In The Last Decade

Jun Naniwa

18 papers receiving 389 citations

Peers

Countries citing papers authored by Jun Naniwa

Since Specialization

Citations

This map shows the geographic impact of Jun Naniwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Naniwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Naniwa more than expected).

Fields of papers citing papers by Jun Naniwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Naniwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Naniwa. The network helps show where Jun Naniwa may publish in the future.

Co-authors

The 17 scholars most cited alongside Jun Naniwa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Naniwa Line = papers co-authored together Jun Naniwa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Combination chemotherapy of oxaliplatin and 5‐fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy Cancer Science ·Seiya Sato, Hiroaki Itamochi, Junzo Kigawa, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Jun Naniwa, Kazunori Uegaki, Michiko Nonaka, Naoki Terakawa	2008	61
2	PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma Oncology Reports ·Kazunori Uegaki, Yasunobu Kanamori, Junzo Kigawa, Wakae Kawaguchi, Ruri Kaneko, Jun Naniwa, Masakuni Takahashi, Muneaki Shimada, Tetsuro Oishi, Hiroaki Itamochi, Naoki Terakawa	2005	52
3	Expression of the c‐myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer Cancer Science ·Takahiro Iba, Junzo Kigawa, Yasunobu Kanamori, Hiroaki Itamochi, Tetsuro Oishi, Muneaki Simada, Kazunori Uegaki, Jun Naniwa, Naoki Terakawa	2004	41
4	Checkpoint Kinase Inhibitor AZD7762 Overcomes Cisplatin Resistance in Clear Cell Carcinoma of the Ovary International Journal of Gynecological Cancer ·Hiroaki Itamochi, Mayumi Nishimura, Nao Oumi, Misaki Kato, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Jun Naniwa, Seiya Sato, Akiko Kudoh, Junzo Kigawa, Tasuku Harada	2013	38
5	The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma Oncology Reports ·Tetsuro Oishi, Hiroaki Itamochi, Akiko Kudoh, Michiko Nonaka, Misaki Kato, Mayumi Nishimura, Nao Oumi, Seiya Sato, Jun Naniwa, Shinya Sato, Muneaki Shimada, Junzo Kigawa, Tasuku Harada	2014	35
6	Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer International Journal of Gynecological Cancer ·Jun Naniwa, Junzo Kigawa, Yasunobu Kanamori, Hiroaki Itamochi, Tetsuro Oishi, Muneaki Shimada, Ruri Shimogai, Wakae Kawaguchi, Seiya Sato, Naoki Terakawa	2006	30
7	Inhibiting the mTOR Pathway Synergistically Enhances Cytotoxicity in Ovarian Cancer Cells Induced by Etoposide through Upregulation of c-Jun Clinical Cancer Research ·Hiroaki Itamochi, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Kazunori Uegaki, Jun Naniwa, Seiya Sato, Michiko Nonaka, Naoki Terakawa, Junzo Kigawa, Tasuku Harada	2011	24
8	Preoperative and Intraoperative Assessments of Depth of Myometrial Invasion in Endometrial Cancer International Journal of Gynecological Cancer ·Shinya Sato, Hiroaki Itamochi, Muneaki Shimada, Shinya Fujii, Jun Naniwa, Kazunori Uegaki, (unknown), (unknown), Michiko Nonaka, Toshihide Ogawa, Junzo Kigawa	2009	23
9	Dual Inhibition of Phosphatidylinositol 3’-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach for Mucinous Adenocarcinoma of the Ovary International Journal of Gynecological Cancer ·Akiko Kudoh, Tetsuro Oishi, Hiroaki Itamochi, Seiya Sato, Jun Naniwa, Shinya Sato, Muneaki Shimada, Junzo Kigawa, Tasuku Harada	2014	16
10	Outcome of stage IB2–IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy International Journal of Clinical Oncology ·Kazunori Uegaki, Muneaki Shimada, Seiya Sato, Imari Deura, Jun Naniwa, Shinya Sato, Tetsuro Oishi, Hiroaki Itamochi, Tasuku Harada, Junzo Kigawa	2013	14
11	Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene Human Cell ·Hiroaki Itamochi, Misaki Kato, Mayumi Nishimura, Nao Oumi, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Jun Naniwa, Seiya Sato, Michiko Nonaka, Akiko Kudoh, Naoki Terakawa, Junzo Kigawa, Tasuku Harada	2013	12
12	PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells Cell and Tissue Research ·Kazunori Uegaki, Yasunobu Kanamori, Junzo Kigawa, Wakae Kawaguchi, Ruri Kaneko, Jun Naniwa, Masakuni Takahashi, Muneaki Shimada, Tetsuro Oishi, Hiroaki Itamochi, Naoki Terakawa	2005	12
13	Activation of the Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Overcomes Cisplatin Resistance in Ovarian Carcinoma Cells International Journal of Gynecological Cancer ·Michiko Nonaka, Hiroaki Itamochi, Wakae Kawaguchi, Akiko Kudoh, Seiya Sato, Kazunori Uegaki, Jun Naniwa, Shinya Sato, Muneaki Shimada, Tetsuro Oishi, Naoki Terakawa, Junzo Kigawa, Tasuku Harada	2012	12
14	Leptomycin B enhances CDDP‐sensitivity via nuclear accumulation of p53 protein in HPV‐positive cells Cancer Science ·Jun Naniwa, Junzo Kigawa, Ryoji Akeshima, Yasunobu Kanamori, Hiroaki Itamochi, Tetsuro Oishi, Takahiro Iba, Naoki Terakawa	2003	11
15	Activity of docetaxel in paclitaxel-resistant ovarian cancer cells Cancer Chemotherapy and Pharmacology ·Shinya Sato, Junzo Kigawa, Yasunobu Kanamori, Hiroaki Itamochi, Tetsuro Oishi, Muneaki Shimada, Takahiro Iba, Jun Naniwa, Kazunori Uegaki, Naoki Terakawa	2004	9
16	Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2 Human Cell ·Hiroaki Itamochi, Misaki Kato, Mayumi Nishimura, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Jun Naniwa, Seiya Sato, Michiko Nonaka, Akiko Kudoh, Naoki Terakawa, Junzo Kigawa, Tasuku Harada	2012	5
17	Abstract 2561: Inhibiting the mTOR pathway synergistically enhances etoposide-induced cytotoxicity by upregulating c-Jun in ovarian cancer cells Cancer Research ·Hiroaki Itamochi, Michiko Nonaka, Seiya Sato, Kazunori Uegaki, Jun Naniwa, Shinya Sato, Muneaki Shimada, Oishi Tetsuro, Naoki Terakawa, Junzo Kigawa, Tasuku Harada	2011	3
18	Abstract 3256: A novel therapy for mucinous adenocarcinoma of the ovary by using NVP-BEZ235 to inhibit PI3K and mTOR. Cancer Research ·Akiko Kudoh, Tetsuro Oishi, Hiroaki Itamochi, Michiko Nonaka, Seiya Sato, Jun Naniwa, Shinya Sato, Muneaki Shimada, Naoki Terakawa, Junzo Kigawa, Tasuku Harada	2013	1
19	Recurrent spontaneous pneumothorax following chemotherapy in a patient with ovarian granulosa cell tumor International Cancer Conference Journal ·Jun Naniwa, Hiroaki Itamochi, Yasushi Horie, Akiko Kudoh, Seiya Sato, Shinya Sato, Muneaki Shimada, Tetsuro Oishi, Junzo Kigawa, Tasuku Harada	2014	0

About Jun Naniwa

Jun Naniwa is a scholar working on Molecular Biology, Reproductive Medicine, Pathology and Forensic Medicine, Oncology and Surgery, having authored 19 papers that have together received 399 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer Mechanisms and Therapy (5 papers), Endometrial and Cervical Cancer Treatments (2 papers), PARP inhibition in cancer therapy (2 papers), Microtubule and mitosis dynamics (2 papers), Endometriosis Research and Treatment (2 papers) and Reproductive Biology and Fertility (2 papers). The work is most often cited by research in Reproductive Medicine (158 citations), Obstetrics and Gynecology (75 citations), Pathology and Forensic Medicine (79 citations), Oncology (114 citations) and Cancer Research (53 citations). Jun Naniwa has collaborated with scholars based in Japan. Frequent co-authors include Junzo Kigawa, Hiroaki Itamochi, Tetsuro Oishi, Muneaki Shimada, Naoki Terakawa, Seiya Sato, Shinya Sato, Yasunobu Kanamori, Michiko Nonaka and Tasuku Harada. Their work appears in journals such as International Journal of Gynecological Cancer, Cancer Science, Human Cell, Oncology Reports and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact